Approvals/TGA/DEXRAZOXANE-REACH dexrazoxane 250 mg powder for injection for infusion vial

Approved

STANDARD

DEXRAZOXANE-REACH dexrazoxane 250 mg powder for injection for infusion vial

Reach Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8e5c2bc7152d32f3
Product Name: DEXRAZOXANE-REACH dexrazoxane 250 mg powder for injection for infusion vial
Artg Id: 428033
Artg Name: DEXRAZOXANE-REACH dexrazoxane 250 mg powder for injection for infusion vial
Sponsor: Reach Pharmaceuticals Pty Ltd
Company Detail Path: /organization/reach-pharmaceuticals-pty-ltd
Artg Date: 2025-03-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b60db7d90dc62d9cd371469ee8b1911e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e3c76da7f91eb08a6480a2791ea88e6a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

8e5c2bc7152d32f3

Type

Standard